No Data
No Data
Earnings Call Summary | Karyopharm Therapeutics(KPTI.US) Q2 2024 Earnings Conference
With 58% Ownership, Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Boasts of Strong Institutional Backing
Results: Karyopharm Therapeutics Inc. Confounded Analyst Expectations With A Surprise Profit
Karyopharm Therapeutics: A Cautious Hold Amid Steady Performance and Pipeline Uncertainties
Express News | HC Wainwright & Co. Reiterates Buy on Karyopharm Therapeutics, Maintains $7 Price Target
Express News | Baird Maintains Outperform on Karyopharm Therapeutics, Lowers Price Target to $5
No Data